Neural Regeneration Research, 2020 · DOI: 10.4103/1673-5374.272566 · Published: January 9, 2020
N-formyl peptide receptors (FPRs) are a family of receptors that play a role in the body's defense and inflammation. They were initially found on phagocytic leukocytes, but research has revealed roles beyond the immune system. FPRs are expressed in neuronal tissues, especially in the central nervous system. Interactions between FPRs and endogenous ligands have been linked to the development of neurodegenerative diseases like Alzheimer’s and Parkinson’s, as well as neurological cancers. This review summarizes recent progress in understanding the role of FPRs in a neuronal setting and proposes them as a potential therapeutic target for nervous system conditions, potentially opening doors to novel neuronal regeneration therapies.
FPRs could be a novel therapeutic target for future drug development, potentially reducing neurodegenerative disease progression by overcoming FPR-mediated inflammatory signaling.
FPR transduction in neurogenesis could be exploited for NSCs to target areas of inflammation or damage in the nervous system and regenerate damaged neuronal tissue.
FPR antagonists could be administered to curtail undesirable neuronal differentiation and potentially halt neuroma formation, preventing neuropathic pain.